Intra vitreal use of Avastin is back
After the Drug Controller General India (DCGI) issued an alert / ban against the intravitreal use of Avastin, a core committee was formed by the leadership of All India Ophthalmological Society (AIOS) and the Vitreo-Retinal Society of India (VRSI) to resolve this issue.
The team led by Dr D Ramamurthy, President-Elect, AIOS met the union Health Secretary on 2nd February. Detailed dossiers were also sent to the PMO, Health Minister and the DCGI.
The DCGI called for a meeting of an expert committee from various leading ophthalmic institutions and representatives of AIOS-VRSI yesterday on 8th Feb. The meeting was also attended by the top representatives of Roche, which manufactures Avastin.
The main outcomes of the meeting were as follows: